MADRID, Spain and CAMBRIDGE, Mass., July 13, 2021 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop ...
Owlstone Medical (“Owlstone”), the global leader in Breath Biopsy ® for applications in early disease detection and precision medicine, today announced recruitment of the first patient into its ...